181 related articles for article (PubMed ID: 37540334)
1. hUC-MSC-EV-miR-24 enhances the protective effect of dexmedetomidine preconditioning against myocardial ischemia-reperfusion injury through the KEAP1/Nrf2/HO-1 signaling.
Hou Z; Yang F; Chen K; Wang Y; Qin J; Liang F
Drug Deliv Transl Res; 2024 Jan; 14(1):143-157. PubMed ID: 37540334
[TBL] [Abstract][Full Text] [Related]
2. Role of Keap1-Nrf2/ARE signal transduction pathway in protection of dexmedetomidine preconditioning against myocardial ischemia/reperfusion injury.
Li HX; Wang TH; Wu LX; Xue FS; Zhang GH; Yan T
Biosci Rep; 2022 Sep; 42(9):. PubMed ID: 35959640
[TBL] [Abstract][Full Text] [Related]
3. [MicroRNA-204 Carried by Exosomes of Human Umbilical Cord-derived Mesenchymal Stem Cells Regulates the Polarization of Macrophages in a Mouse Model of Myocardial Ischemia-reperfusion Injury].
Yuan G; Yang D; Luo L; Wen W
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Oct; 44(5):785-793. PubMed ID: 36325775
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665/MEF2D/Nrf2 axis.
Wang L; Liu J; Wang Z; Qian X; Zhao Y; Wang Q; Dai N; Xie Y; Zeng W; Yang W; Bai X; Yang Y; Qian J
Biomed Pharmacother; 2023 Sep; 165():115255. PubMed ID: 37549462
[TBL] [Abstract][Full Text] [Related]
5. miR-432-5p Inhibits the Ferroptosis in Cardiomyocytes Induced by Hypoxia/Reoxygenation via Activating Nrf2/SLC7A11 Axis by Degrading Keap1.
Geng W; Yan S; Li X; Liu Q; Zhang X; Gu X; Tian X; Jiang Y
Anal Cell Pathol (Amst); 2023; 2023():1293200. PubMed ID: 37822721
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA miR-24-3p Reduces Apoptosis and Regulates Keap1-Nrf2 Pathway in Mouse Cardiomyocytes Responding to Ischemia/Reperfusion Injury.
Xiao X; Lu Z; Lin V; May A; Shaw DH; Wang Z; Che B; Tran K; Du H; Shaw PX
Oxid Med Cell Longev; 2018; 2018():7042105. PubMed ID: 30622671
[TBL] [Abstract][Full Text] [Related]
7.
Cao H; Cheng Y; Gao H; Zhuang J; Zhang W; Bian Q; Wang F; Du Y; Li Z; Kong D; Ding D; Wang Y
ACS Nano; 2020 Apr; 14(4):4014-4026. PubMed ID: 32212674
[TBL] [Abstract][Full Text] [Related]
8. MSC-Derived Small Extracellular Vesicles Attenuate Autoimmune Dacryoadenitis by Promoting M2 Macrophage Polarization and Inducing Tregs
Li N; Gao Z; Zhao L; Du B; Ma B; Nian H; Wei R
Front Immunol; 2022; 13():888949. PubMed ID: 35874782
[TBL] [Abstract][Full Text] [Related]
9. Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate rat hepatic ischemia-reperfusion injury by suppressing oxidative stress and neutrophil inflammatory response.
Yao J; Zheng J; Cai J; Zeng K; Zhou C; Zhang J; Li S; Li H; Chen L; He L; Chen H; Fu H; Zhang Q; Chen G; Yang Y; Zhang Y
FASEB J; 2019 Feb; 33(2):1695-1710. PubMed ID: 30226809
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of miR-200a protects cardiomyocytes against hypoxia-induced apoptosis by modulating the kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 signaling axis.
Sun X; Zuo H; Liu C; Yang Y
Int J Mol Med; 2016 Oct; 38(4):1303-11. PubMed ID: 27573160
[TBL] [Abstract][Full Text] [Related]
11. Human umbilical cord mesenchymal stem cells-derived exosomal circDLGAP4 promotes angiogenesis after cerebral ischemia-reperfusion injury by regulating miR-320/KLF5 axis.
Feng J; He W; Xia J; Huang Q; Yang J; Gu WP; Zhang N; Liu YH
FASEB J; 2023 Mar; 37(3):e22733. PubMed ID: 36723877
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization.
Zhao J; Li X; Hu J; Chen F; Qiao S; Sun X; Gao L; Xie J; Xu B
Cardiovasc Res; 2019 Jun; 115(7):1205-1216. PubMed ID: 30753344
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin-pretreated mesenchymal stem cell-derived extracellular vesicles promote cardiac repair after myocardial infarction via shifting macrophage polarization by targeting microRNA-139-3p/Stat1 pathway.
Ning Y; Huang P; Chen G; Xiong Y; Gong Z; Wu C; Xu J; Jiang W; Li X; Tang R; Zhang L; Hu M; Xu J; Xu J; Qian H; Jin C; Yang Y
BMC Med; 2023 Mar; 21(1):96. PubMed ID: 36927608
[TBL] [Abstract][Full Text] [Related]
14. microRNA-100 shuttled by human umbilical cord MSC-secreted extracellular vesicles induces endometriosis by inhibiting HS3ST2.
Zhang F; Li F; Lu J
Cell Signal; 2023 Feb; 102():110532. PubMed ID: 36423858
[TBL] [Abstract][Full Text] [Related]
15. Restoration of NRF2 attenuates myocardial ischemia reperfusion injury through mediating microRNA-29a-3p/CCNT2 axis.
Tian R; Guan X; Qian H; Wang L; Shen Z; Fang L; Liu Z
Biofactors; 2021 May; 47(3):414-426. PubMed ID: 33600051
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis.
Wang Z; Yang Y; Xiong W; Zhou R; Song N; Liu L; Qian J
Biomed Pharmacother; 2020 May; 125():110001. PubMed ID: 32070878
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment with Panaxatriol Saponin Attenuates Mitochondrial Apoptosis and Oxidative Stress to Facilitate Treatment of Myocardial Ischemia-Reperfusion Injury via the Regulation of Keap1/Nrf2 Activity.
Yao H; Xie Q; He Q; Zeng L; Long J; Gong Y; Li X; Li X; Liu W; Xu Z; Wu H; Zheng C; Gao Y
Oxid Med Cell Longev; 2022; 2022():9626703. PubMed ID: 35669855
[TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine alleviates myocardial ischemia/reperfusion-induced injury and Ca
Zheng X; Li J; Fan Q; Zhao X; Chen K
Int J Cardiol; 2021 Sep; 338():185-195. PubMed ID: 33731281
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine inhibits pyroptosis by down-regulating miR-29b in myocardial ischemia reperfusion injury in rats.
Zhong Y; Li YP; Yin YQ; Hu BL; Gao H
Int Immunopharmacol; 2020 Sep; 86():106768. PubMed ID: 32679539
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine exerts cerebral protective effects against cerebral ischemic injury by promoting the polarization of M2 microglia via the Nrf2/HO-1/NLRP3 pathway.
Wang N; Nie H; Zhang Y; Han H; Wang S; Liu W; Tian K
Inflamm Res; 2022 Jan; 71(1):93-106. PubMed ID: 34767031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
